- Home
- COLL vs EE Comparison
COLL vs EE Comparison
Compare COLL & EE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COLL
- EE
- Stock Information
- Founded
- COLL 2002
- EE 2003
- Country
- COLL United States
- EE United States
- Employees
- COLL N/A
- EE N/A
- Industry
- COLL Biotechnology: Pharmaceutical Preparations
- EE Oil/Gas Transmission
- Sector
- COLL Health Care
- EE Utilities
- Exchange
- COLL Nasdaq
- EE Nasdaq
- Market Cap
- COLL 958.8M
- EE 914.5M
- IPO Year
- COLL 2015
- EE 2022
- Fundamental
- Price
- COLL $31.60
- EE $26.56
- Analyst Decision
- COLL Strong Buy
- EE Hold
- Analyst Count
- COLL 4
- EE 7
- Target Price
- COLL $43.75
- EE $32.29
- AVG Volume (30 Days)
- COLL 291.1K
- EE 492.5K
- Earning Date
- COLL 08-07-2025
- EE 08-06-2025
- Dividend Yield
- COLL N/A
- EE 0.90%
- EPS Growth
- COLL N/A
- EE 37.63
- EPS
- COLL 1.25
- EE 1.53
- Revenue
- COLL $664,283,000.00
- EE $966,414,000.00
- Revenue This Year
- COLL $20.23
- EE $36.94
- Revenue Next Year
- COLL $3.82
- EE $18.61
- P/E Ratio
- COLL $25.23
- EE $17.50
- Revenue Growth
- COLL 17.17
- EE N/A
- 52 Week Low
- COLL $23.23
- EE $17.54
- 52 Week High
- COLL $42.29
- EE $32.99
- Technical
- Relative Strength Index (RSI)
- COLL 61.58
- EE 31.08
- Support Level
- COLL $31.53
- EE $25.72
- Resistance Level
- COLL $32.95
- EE $29.27
- Average True Range (ATR)
- COLL 0.88
- EE 0.77
- MACD
- COLL 0.06
- EE -0.28
- Stochastic Oscillator
- COLL 73.51
- EE 9.16
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.
About EE Excelerate Energy Inc.
Excelerate Energy Inc offers LNG solutions, providing integrated services along the LNG value chain. It offers a full range of regasification services, from FSRUs to infrastructure development, to LNG and natural gas supply. Its business spans the globe, with a regional presence in 11 countries and an operational presence in Argentina, Bangladesh, Brazil, Finland, Germany, Pakistan, the United Arab Emirates (UAE), and the United States.